- $3.45bn
- $3.08bn
- $379.81m
Brief: Caredx Reports Preliminary Revenue Results For Q4
U.S. RESEARCH ROUNDUP-Caredx, Ebix, Vera Therapeutics
Brief: CareDx Q3 Adjusted EPS USD -0.18 Vs. IBES Estimate USD -0.4
CareDx Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Natera Says US Supreme Court Denied Caredx Petition For Certiorari On A Patent Infringement Lawsuit
US Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests
Brief: CareDx Inc Says By Letter Dated Sept 19, Co Was Notified By Staff Of United States SEC That SEC Has Concluded Its Investigation As To Co
CareDx Inc reports results for the quarter ended in June - Earnings Summary
Brief: CareDx Q2 Adjusted EPS USD -0.18 Vs. IBES Estimate USD -0.31
CareDx Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: CareDx’s Heartcare Multimodality Service Receives Medicare Coverage For Heart Transplant Surveillance
CareDx Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: CareDx Acquires MediGO, An Organ Transplant Supply Chain And Logistics Company
US judge rejects $45 mln award to CareDx in Natera false ads case
Brief: CareDx's Allosure Lung dd-cfDNA Testing Service Receives Medicare Coverage For Lung Transplant Rejection Monitoring
U.S. STOCKS ON THE MOVE-Alphabet, WW International, JD.com
U.S. STOCKS ON THE MOVE-KLX Energy, Goodyear Tire, Steris
CareDx hits over 5-yr low on withdrawing annual revenue outlook
U.S. STOCKS ON THE MOVE-Blade Air Mobility, Charles River, Krispy Kreme